Home » Stocks » QDEL

Quidel Corporation (QDEL)

Stock Price: $142.95 USD 0.50 (0.35%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $141.00 -1.95 (-1.36%) Jul 29, 7:40 PM
Market Cap 6.03B
Revenue (ttm) 1.86B
Net Income (ttm) 948.13M
Shares Out 42.51M
EPS (ttm) 21.74
PE Ratio 6.58
Forward PE 20.33
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $142.95
Previous Close $142.45
Change ($) 0.50
Change (%) 0.35%
Day's Open 142.99
Day's Range 142.30 - 145.59
Day's Volume 336,968
52-Week Range 103.31 - 306.72

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

The company's next earnings report could be another disappointment.

1 day ago - The Motley Fool

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announc...

3 days ago - Business Wire

Stocks for companies developing or already distributing a vaccine for covid are on the move Tuesday and we've got all the details. The post Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on the...

Other stocks mentioned: IMNM, MRNA, NRBO, NVAX, OCGN
1 week ago - InvestorPlace

The company announces a potentially major testing deal in Delaware.

1 week ago - The Motley Fool

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

1 week ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fisc...

2 weeks ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

2 weeks ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)-- #LymeDisease--Americans looking for information regarding Lyme disease have a new and trusted resource in which to rely with the launch of LymeDiseaseAnswers.com.

2 weeks ago - Business Wire

Quidel (QDEL) closed at $121.25 in the latest trading session, marking a +0.82% move from the prior day.

3 weeks ago - Zacks Investment Research

Quidel Corporation (NASDAQ: QDEL) is recalling its Lyra COVID-19 Assay test due to a high risk of false-negative results in patients with high amounts of the virus. The FDA gave the molecular COVID-19 t...

3 weeks ago - Benzinga

A Covid-19 swab test is being recalled due to a risk of false negative results.

3 weeks ago - CNBC

Quidel (QDEL) closed at $128.60 in the latest trading session, marking a +0.37% move from the prior day.

4 weeks ago - Zacks Investment Research

There might be a surge in demand for coronavirus testing kits in the very near future.

1 month ago - The Motley Fool

SAN DIEGO, Calif.--(BUSINESS WIRE)-- #LymeDisease--To help camp directors and counselors heighten their awareness of Lyme disease, a public service campaign has been launched by Quidel Corporation.

1 month ago - Business Wire

Quidel (QDEL) closed at $114.96 in the latest trading session, marking a +1.87% move from the prior day.

1 month ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)-- #LymeDisease--Lyme disease is on the rise nationwide and has the potential to affect as many as 476,000 citizens before the year is out.

1 month ago - Business Wire

We believe that there are other stocks in the healthcare sector that are currently better valued than Aboott Laboratories. Abbott's current price-to-operating income ratio (P/EBIT) of 30x is much higher...

Other stocks mentioned: PKI
1 month ago - Forbes

Analysts view all three as rebound candidates.

Other stocks mentioned: IONS, SMG
1 month ago - The Motley Fool

Quidel (QDEL) closed the most recent trading day at $113.80, moving +0.92% from the previous trading session.

1 month ago - Zacks Investment Research

Quidel (QDEL) closed the most recent trading day at $112.03, moving +0.93% from the previous trading session.

1 month ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced tod...

1 month ago - Business Wire

Bear of the Day: Quidel (QDEL)

1 month ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today ...

1 month ago - Business Wire

Quidel (QDEL) closed the most recent trading day at $112.42, moving +0.64% from the previous trading session.

1 month ago - Zacks Investment Research

We believe that the stock price of Quidel, a clinical genetic testing company, looks undervalued at current levels near $108. QDEL stock is actually up just 22% from levels of around $88 it was at on Ma...

1 month ago - Forbes

We think that Quidel currently is a better pick compared to Abbott. QDEL stock trades at about 3.1x trailing revenues, compared to around 5.6x for Abbott.

Other stocks mentioned: ABT
1 month ago - Forbes

These companies have a lot of room for growth -- and they could take you for quite a ride.

Other stocks mentioned: ETSY, ZNGA
2 months ago - The Motley Fool

The pandemic bolstered many stocks to buy. But with cases fading, this narrative is now questionable.

Other stocks mentioned: APT, GILD, IBIO, INO, NVAX, SRNE
2 months ago - InvestorPlace

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it ...

2 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

2 months ago - Business Wire

Investors rewarded the stock for triple-digit growth, but the market remains unsure about the remainder of 2021.

2 months ago - The Motley Fool

Quidel (QDEL) delivered earnings and revenue surprises of -10.06% and 0.03%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Quidel (NASDAQ:QDEL) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 259.02% year over year to $4.38, which missed the e...

2 months ago - Benzinga

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financia...

2 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

2 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today ...

2 months ago - Business Wire

Quidel (QDEL) is likely to have witnessed recovery in rapid immunoassay revenues during Q1.

2 months ago - Zacks Investment Research

An important indicator for investors to consider could be a stock's 52-week trading range, the range showing the lowest and highest price a particular stock traded over the trailing year. Finding stocks...

Other stocks mentioned: IRTC, METX, SPLK
2 months ago - Benzinga

Bear of the Day: Quidel (QDEL)

2 months ago - Zacks Investment Research

Diagnostic test manufacturer Quidel's stock has slumped for good reason. Even so, this might be a good time to buy it.

2 months ago - The Motley Fool

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

AJRD, HRTG, LMB, QDEL, and SPFI have been added to the Zacks Rank #5 (Strong Sell) List on April 29, 2021

Other stocks mentioned: AJRD, HRTG, LMB, SPFI
3 months ago - Zacks Investment Research

Market sentiment about these formerly hot stocks has soured, but there are positive catalysts for both on the horizon.

Other stocks mentioned: TDOC
3 months ago - The Motley Fool

FBC, IDCC, PAAS, COG, and QDEL have been added to the Zacks Rank #5 (Strong Sell) List on April 27, 2021

Other stocks mentioned: COG, FBC, IDCC, PAAS
3 months ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)-- #LymeDisease--May 5 webinar to help physicians differentiate between Lyme disease and COVID-19 is the latest in an ongoing series sponsored by Quidel.

3 months ago - Business Wire

Although these stocks are down of late, their promising growth opportunities could lift them back up.

Other stocks mentioned: FUBO
3 months ago - The Motley Fool

The stock price of Quidel Corporation, a clinical genetic testing company, has seen a 10% drop in just five trading sessions. The decline was driven primarily due to the company's preliminary report for...

3 months ago - Forbes

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fisc...

3 months ago - Business Wire

Quidel Corporation (NASDAQ: QDEL) shares witnessed a drop after announcing lower-than-expected preliminary results for Q1 of 2021 after the bell on Thursday. The company expects Q1 revenues in the range...

3 months ago - Benzinga

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

3 months ago - Business Wire

About QDEL

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables... [Read more...]

Industry
Diagnostics & Research
Founded
1979
CEO
Douglas Bryant
Employees
1,370
Stock Exchange
NASDAQ
Ticker Symbol
QDEL
Full Company Profile

Financial Performance

In 2020, QDEL's revenue was $1.66 billion, an increase of 210.66% compared to the previous year's $534.89 million. Earnings were $810.29 million, an increase of 1,011.18%.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for QDEL stock is "Buy." The 12-month stock price forecast is 146.50, which is an increase of 2.48% from the latest price.

Price Target
$146.50
(2.48% upside)
Analyst Consensus: Buy